Bioventus (BVS) director Hawkins granted 30,994 RSUs and exercises 39,789 into shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Bioventus Inc. director William A. Hawkins reported equity compensation activity involving restricted stock units (RSUs) and Class A common stock. On June 3, 2026, he received a grant of 30,994 RSUs, each representing a contingent right to receive one share of Class A common stock, with vesting tied to continued board service.
On June 2, 2026, 39,789 RSUs vested and were exercised into 39,789 shares of Class A common stock. Following these transactions, Hawkins directly owned 297,640 shares of Class A common stock and held 30,994 RSUs as a separate derivative position, reflecting routine director compensation and vesting rather than open-market trading.
Positive
- None.
Negative
- None.
Insider Trade Summary
39,789 shares exercised/converted
Mixed
3 txns
Insider
HAWKINS WILLIAM A
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 30,994 | $0.00 | -- |
| Exercise | Restricted Stock Units | 39,789 | $0.00 | -- |
| Exercise | Class A Common Stock | 39,789 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Units — 30,994 shares (Direct, null);
Class A Common Stock — 297,640 shares (Direct, null)
Footnotes (1)
- Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. The RSUs vested on June 2, 2026. The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date.
Key Figures
New RSU grant: 30,994 RSUs
RSUs exercised: 39,789 RSUs
Shares received from exercise: 39,789 shares
+2 more
5 metrics
New RSU grant
30,994 RSUs
Grant of restricted stock units on June 3, 2026
RSUs exercised
39,789 RSUs
Vested and converted to Class A common stock on June 2, 2026
Shares received from exercise
39,789 shares
Class A common stock received upon RSU vesting and exercise
Direct common stock holdings
297,640 shares
Class A common stock owned directly after transactions
RSUs outstanding after grant
30,994 RSUs
Restricted stock units held as derivative position after new award
Key Terms
Restricted Stock Units, Class A Common Stock, Grant, award, or other acquisition, Exercise or conversion of derivative security, +1 more
5 terms
Restricted Stock Units financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Class A Common Stock financial
"underlying_security_title: "Class A Common Stock" with 39,789.0000 underlying shares"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
Grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition" for the RSU grant"
Exercise or conversion of derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security" for the RSU vesting"
contingent right financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock."
FAQ
What insider transactions did Bioventus (BVS) director William A. Hawkins report?
Bioventus director William A. Hawkins reported equity compensation activity, including a grant of restricted stock units and the vesting and exercise of previously granted RSUs into Class A common stock, with no open-market purchases or sales disclosed in this Form 4.
How many restricted stock units did Hawkins receive from Bioventus (BVS)?
Hawkins received a grant of 30,994 restricted stock units. Each RSU represents a contingent right to receive one share of Bioventus Class A common stock, subject to specific vesting conditions tied to his continued service on the company’s board of directors.
Are Hawkins’ Bioventus (BVS) transactions open-market buys or sells?
The reported transactions are not open-market buys or sells. They consist of a grant of restricted stock units and the vesting and exercise of existing RSUs into Class A common stock, which is standard equity compensation rather than discretionary trading in the public market.
What are the vesting terms for Hawkins’ new Bioventus RSU grant?
The 30,994 RSUs will vest on the earlier of the day immediately preceding Bioventus’ first annual stockholder meeting following the grant date or the first anniversary of the grant date, provided Hawkins continues serving on the company’s board through the applicable vesting date.